TherapeuticsMD, Inc. (TXMD): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$34.0K
Year ended 2021-12-31
-46.1%
3-year compound annual growth
-38.8%
5-year compound annual growth
+1.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $34.0K | -83.6% | 2023-04-07, From 2021-01-01 |
| 2020-12-31 | $207.0K | -91.6% | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | $2.45M | n/m | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $217.0K | +251.1% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $61.8K | -84.4% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $396.2K | +139.7% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $165.3K | +433.7% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $31.0K | -24.1% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $40.8K | -38.6% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $66.4K | +130.8% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $28.8K | n/a | 2014-03-05, From 2011-01-01 |